Ramsay Health Care Limited chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 57.13
Dividend & Yield1.52$ (2.09%)
Beta 0.42
Market capitalization 16.14B
Operating cash flow 627.2M
ESG Scores 21.7

Company description

Ramsay Health Care Limited owns and operates hospitals for public and private patients. It also offers health care services. It operates facilities in 460 locations in the Asia Pacific, the United Kingdom, France, and Nordics. The company was founded in 1964 and is based in Sydney, Australia.

Sector: Healthcare - Industry: Medical Care Facilities

Financial Ratios
Quick Ratio1.33
Working Capital0.27
Return On Equity0.12
Debt To Equity1.39
Fixed Asset Ratio0.03
Fixed Interest Cover1.73

Financial data

Financial Statements

Cashflow Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Change To Liabilities -33.22M 164.4M 890.5M 107.1M
Total Cashflows From Investing Activities -631.88M -1.75B -656M -2.5B
Net Borrowings 354.43M 783.4M -1.36B 735.9M
Total Cash From Financing Activities -14.93M 812M -231.9M 584M
Change To Operating Activities 163.05M -15M -51.6M 43.7M
Issuance Of Stock 1.48B 1.48B 1.48B
Net Income 388.35M 545.5M 284M 449M
Change In Cash 351.05M -25.1M 758.2M -498.9M
Effect Of Exchange Rate 3.17M 11.9M -34.6M -59.9M
Total Cash From Operating Activities 994.69M 903.3M 1.68B 1.48B
Depreciation 379.49M 475.6M 875.1M 884M
Change To Account Receivables 62.31M -299.6M -268.1M -103.9M
Other Cashflows From Financing Activities -23.83M 359.3M -12.6M -36.6M
Change To Netincome 54.06M 6M 16.1M 67.6M
Capital Expenditures -473.84M -593.8M -680.6M -628.9M

Income Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Research Development
Income Before Tax 607.93M 846.8M 466.2M 741.6M
Net Income 388.35M 545.5M 284M 449M
Selling General Administrative
Gross Profit 1.22B 1.54B 1.58B 1.59B
Ebit 832.7M 1.05B 689M 690.7M
Operating Income 832.7M 1.05B 689M 690.7M
Interest Expense -116.55M -175.4M -423.6M -398.1M
Income Tax Expense 196.71M 274.4M 157M 230.1M
Total Revenue 9.18B 11.55B 12.16B 12.86B
Cost Of Revenue 7.95B 10.02B 10.58B 11.27B
Total Other Income ExpenseNet -224.78M -204.3M -222.8M 50.9M
Net Income From Continuing Ops 411.21M 572.4M 309.2M 511.5M
Net Income Applicable To Common Shares 376.02M 532.7M 272.7M 439.9M

Balance Sheet Statement 2018-06-30 2019-06-30 2020-06-30 2021-06-30
Total Liabilities 6.87B 9.62B 13.86B 14.77B
Total Stockholder Equity 2.1B 2.29B 3.5B 3.78B
Other Current Liabilities 437.48M 704.2M 1.23B 1.04B
Total Assets 9.31B 12.64B 18.1B 19.32B
Common Stock 713.52M 713.5M 2.2B 2.2B
Other Current Assets 44.98M 43.1M 39.2M 1.99B
Retained Earnings 1.49B 1.69B 1.43B 1.75B
Treasury Stock -103.01M -115.3M -129.2M -168M
Cash 770.57M 745.5M 1.5B 1B
Total Current Liabilities 2B 2.74B 3.77B 3.72B
Other Stockholder Equity -26.26M -33.2M -51M -91.3M
Property, Plant, and Equipment 4.11B 4.64B 8.93B 8.9B
Total Current Assets 2.37B 2.92B 4.06B 5.35B
Net Tangible Assets -157.71M -1.97B -745.8M -453.1M
Net Receivables 1.17B 1.61B 1.93B 1.81B
Accounts Payable 775.25M 1.04B 1.15B 1.16B


Insider Transactions

Here are the insider transactions of stock shares related to Ramsay Health Care Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Penrose (Karen Lee Collett)Other at price 48.71 per share.D2022-04-29Director (Non-Executive)580
McNally (Craig Ralph)Other at price 48.66 per share.D2021-11-13Chief Executive Officer17.29k
Roberts (Martyn)D2021-06-30Chief Financial Officer3.07k
Dyckerhoff (Claudia Ricarda Rita Sussmuth)Purchase at price 45.46 per share.D2020-06-12Director (Non-Executive)2.5k
Deans (Catriona Alison)Other at price 37.07 per share.D2020-05-27Director (Non-Executive)1.94k
Evans (Peter John)Other at price 37.07 per share.D2020-05-27Director (Non-Executive)535
McNally (Craig Ralph)Other at price 37.07 per share.D2020-05-27Chief Executive Officer535
Penrose (Karen Lee Collett)Other at price 0.16 per share.D2020-05-27Director (Non-Executive)232
Thodey (David Ingle)Other at price 37.07 per share.D2020-05-27Director (Non-Executive)535
Thodey (David Ingle)D2020-05-05Director (Non-Executive)551
Penrose (Karen Lee Collett)Purchase at price 41.26 per share.D2020-03-11Director (Non-Executive)725
Thodey (David Ingle)Other at price 42.68 per share.D2020-03-02Director (Non-Executive)675
Deans (Catriona Alison)Other at price 42.68 per share.D2020-03-02Director (Non-Executive)675
Dyckerhoff (Claudia Ricarda Rita Sussmuth)Other at price 42.68 per share.D2020-03-02Director (Non-Executive)675
Evans (Peter John)Other at price 42.68 per share.D2020-03-02Director (Non-Executive)675
McMurdo (James)Other at price 42.68 per share.D2020-03-02Director (Non-Executive)542
Siddle (Michael Stanley)Other at price 42.68 per share.D2020-03-02Chairman of the Board675
McGeoch (Roderick Hamilton)D2019-11-14Former52.83k
McNally (Craig Ralph)Other at price 45.02 per share.D2019-10-15Chief Executive Officer9.12k
Soden (Bruce Roger)D2019-09-12Former4.13k
Soden (Bruce Roger)Other at price 45.18 per share.D2019-08-30Director (Executive)28.84k
McNally (Craig Ralph)Other at price 45.18 per share.D2019-08-30Chief Executive Officer18.22k
Sims (Danny A)D2019-06-30Other Executive14.37k
McNally (Craig Ralph)Sale at price 45.54 per share.D2019-03-25Chief Executive Officer45k
Soden (Bruce Roger)Sale at price 44.73 per share.D2019-03-08Director (Executive)20k
Soden (Bruce Roger)Sale at price 44.85 per share.D2019-03-07Director (Executive)30k
Thodey (David Ingle)Other at price 39.32 per share.D2019-03-01Director (Non-Executive)793
Deans (Catriona Alison)Other at price 39.32 per share.D2019-03-01Director (Non-Executive)495
Dyckerhoff (Claudia Ricarda Rita Sussmuth)Other at price 39.32 per share.D2019-03-01Director530
Evans (Peter John)Other at price 39.32 per share.D2019-03-01Director (Non-Executive)793
McGeoch (Roderick Hamilton)Other at price 39.32 per share.D2019-03-01Director (Non-Executive)793
Roxburgh (Kerry Chisholm Dart)Other at price 39.32 per share.D2019-03-01Director (Non-Executive)793
Siddle (Michael Stanley)Other at price 39.32 per share.D2019-03-01Chairman of the Board793
Akopiantz (Patricia Elizabeth)D2018-11-09Former1.37k
Seale (Margaret Leone)D2018-10-31Former3.56k
McNally (Craig Ralph)Other at price 37.59 per share.D2018-10-15Chief Executive Officer7.04k
McNally (Craig Ralph)Other at price 40.26 per share.D2018-08-31Chief Executive Officer23.45k
Soden (Bruce Roger)Other at price 40.26 per share.D2018-08-31Director (Executive)37.12k
Sims (Danny A)D2018-06-30Other Executive17.43k
McNally (Craig Ralph)Sale at price 48.05 per share.D2018-04-26Chief Executive Officer68k
McNally (Craig Ralph)Sale at price 48.29 per share.D2018-04-24Chief Executive Officer5.11k
McNally (Craig Ralph)Sale at price 48.29 per share.D2018-04-23Chief Executive Officer1.89k
Roxburgh (Kerry Chisholm Dart)Sale at price 48.69 per share.D2018-03-08Director (Non-Executive)16.42k
Roxburgh (Kerry Chisholm Dart)Sale at price 48.68 per share.D2018-03-07Director (Non-Executive)1.08k
McGeoch (Roderick Hamilton)Purchase at price 49.31 per share.D2018-03-06Director (Non-Executive)4.5k
Akopiantz (Patricia Elizabeth)Other at price 51.98 per share.D2018-03-02Director (Non-Executive)658
Evans (Peter John)Other at price 51.98 per share.D2018-03-02Director (Non-Executive)658
McGeoch (Roderick Hamilton)Other at price 51.98 per share.D2018-03-02Director (Non-Executive)658
McGeoch (Roderick Hamilton)I2018-03-02Director (Non-Executive)
Thodey (David Ingle)Other at price 51.98 per share.D2018-03-02Director (Non-Executive)387
Roxburgh (Kerry Chisholm Dart)Other at price 51.98 per share.D2018-03-02Director (Non-Executive)658

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Ramsay Health Care Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Ramsay Health Care Limited

Here is the result of two systematic investment strategies applied to Ramsay Health Care Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Ramsay Health Care Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Ramsay Health Care Limited:

Ramsay Health Care Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -0.91% on the backtest period.

Performance at glance

Performance

-0.91 %

Latent gain

-19.57 $

Invested capital

2148.73 $

Annualized return

-0.22 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Ramsay Health Care Limited

This is the result of two momentum investment strategies applied to Ramsay Health Care Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Ramsay Health Care Limited

The following chart shows all the entries opened by the momentum investment system on Ramsay Health Care Limited:

Ramsay Health Care Limited momentum entries
  • The first momentum investment strategy would give 4.38% of return on Ramsay Health Care Limited. That represents 240.73$ of latent gain with 5501.55$ of employed capital.
  • The second momentum investment strategy would give 3.15% of return on Ramsay Health Care Limited. That represents 98.4$ of latent gain with 3127.6$ of employed capital.
Performance at glance (1Q Momentum)

Performance

4.38 %

Latent gain

240.73 $

Invested capital

5501.55 $

Annualized return

1.88 %
Performance at glance (2Q Momentum)

Performance

3.15 %

Latent gain

98.4 $

Invested capital

3127.6 $

Annualized return

0.87 %

Momentum equity curve on Ramsay Health Care Limited

The following chart shows the equity curve of the two momentum strategies applied to Ramsay Health Care Limited:

Ramsay Health Care Limited momentum equity

Note: the dividends potentially given by Ramsay Health Care Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Ramsay Health Care Limited

The following chart shows the employed capital evolution of the two momentum strategies on Ramsay Health Care Limited since the beginning:

Ramsay Health Care Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Ramsay Health Care Limited

Buy the dip entry openings on Ramsay Health Care Limited

Ramsay Health Care Limited

The performance achieved by the robo-advisor on Ramsay Health Care Limited is 3.95%. That represents 9.8$ of latent gain with 248.28$ of employed capital. The following chart shows Ramsay Health Care Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Ramsay Health Care Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

3.95 %

Latent gain

9.8 $

Invested capital

248.28 $

Annualized return

1.88 %

Equity curve of the strategy applied to Ramsay Health Care Limited

The following chart shows the result of the investment strategy applied to Ramsay Health Care Limited:

Ramsay Health Care Limited

Note: the dividends potentially given by Ramsay Health Care Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Ramsay Health Care Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Ramsay Health Care Limited:

Ramsay Health Care Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Ramsay Health Care Limited

In this section, I will compare the three previous investment strategies applied to Ramsay Health Care Limited.

Equity curve comparison on Ramsay Health Care Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Ramsay Health Care Limited investment strategy comparison

Employed capital comparison on Ramsay Health Care Limited

Ramsay Health Care Limited investment comparison

Performance comparison on Ramsay Health Care Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -0.91% -19.57$ 2148.73$ -0.22%
Momentum 1 quarter 4.38% 240.73$ 5501.55$ 1.13%
Momentum 2 quarters 3.15% 98.4$ 3127.6$ 0.87%
Non-directional 3.95% 9.8$ 248.28$ 1.88%
Annualized return comparison

Automatic investment

-0.22 %

Momentum 1Q

0.87 %

Momentum 2Q

0.87 %

Non-directional

1.88 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Ramsay Health Care Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Ramsay Health Care Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Ramsay Health Care Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Ramsay Health Care Limited
Country Australia
City Sydney
Address 126 Phillip Street
Phone 61 2 9220 1000
Website www.ramsayhealth.com
FullTime employees 86000
Industry Medical Care Facilities
Sector Healthcare
Exchange XASX
Ticker RHC.XASX
Market www2.asx.com.au

Ramsay Health Care Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 3.2
Peer Environment Performance 2.2440350877193
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing no

Social scores

Social ESG Factors Scores
Social Score 11.2
Peer Social Performance 12.085087719298
Social Percentile unknown
Highest Controversy 1
Peer Highest Controversy Performance 1.9310344827586
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic yes
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer IncidentsGovernance Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 7.3
Peer Governance Performance 7.7398245614035
Governance Percentile unknown

ESG at glance
Total ESG Scores: 21.7
Environment Score: 3.2
Social Score: 11.2
Governance Score: 7.3

ESG Performance: AVG_PERF

Peer Group: Healthcare

Peer Esg Score Performance: 22.091551724138

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 31